VitaSpring Biomedical Co. Ltd. (VSBC) stock
VSBCOTCServices-Commercial Physical & Biological ResearchFiscal year ends January 31
$0.03+0.00 (0.00%)
Close on Oct 19, 2026Market cap $6.58MP/E –Yield –
VitaSpring Biomedical free cash flow
Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.
For fiscal 2023 it was -$77.56K.
Annual free cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2023 | Jan 31, 2023 | -$77.56K | – |
| FY2022 | Jan 31, 2022 | -$342.63K | – |
See a number that looks wrong?